| Insider Name | Buy/Sell | Amount | Shares Change | |||
|---|---|---|---|---|---|---|
| Jul 17, 2023 | Jul 19, 2023 | Gordon Carl L Dir 10% | Buy | $3.05 | $1M | +42.45% |
| Jul 17, 2023 | Jul 19, 2023 | Orbimed Advisors LLC Dir 10% | Buy | $3.05 | $1M | +42.45% |
| Jul 17, 2023 | Jul 19, 2023 | Foresite Capital Management V, LLC 10% | Buy | $2.97 | $2M | +33.56% |
| Dec 29, 2022 | Jan 03, 2023 | Foresite Capital Management V, LLC 10% | Buy | $5 | $3M | +29.25% |
| Dec 29, 2022 | Jan 03, 2023 | Hayden Donald J Jr Dir | Buy | $5 | $49,989 | +50.00% |
| Nov 30, 2022 | Dec 01, 2022 | Dahms Bradford D. CFO | Buy | $6.66 | $10,000 | +19.65% |
| Nov 11, 2022 | Nov 14, 2022 | Clackson Timothy P Pres CEO | Buy | $6.8 | $16,995 | +0.71% |
| Nov 07, 2022 | Nov 09, 2022 | Gordon Carl L Dir 10% | Buy | $5.21 | $1M | +1.10% |
| Nov 07, 2022 | Nov 09, 2022 | Orbimed Advisors LLC Dir 10% | Buy | $5.21 | $1M | +1.10% |
| Jan 19, 2022 | Jan 22, 2022 | Gordon Carl L Dir 10% | Buy | $9.97 | $2M | +0.92% |
| Jan 19, 2022 | Jan 22, 2022 | Orbimed Advisors LLC Dir 10% | Buy | $9.97 | $2M | +0.92% |
| Jan 11, 2022 | Jan 14, 2022 | Gordon Carl L Dir 10% | Buy | $9.9 | $442,750 | +0.26% |
| Jan 11, 2022 | Jan 14, 2022 | Orbimed Advisors LLC Dir 10% | Buy | $9.9 | $442,750 | +0.26% |
| Dec 21, 2021 | Dec 22, 2021 | Clackson Timothy P Pres CEO | Buy | $9.76 | $25,381 | +0.74% |
| Dec 21, 2021 | Dec 22, 2021 | Dahms Bradford D. CFO | Buy | $10.15 | $20,000 | +50.00% |
| Oct 12, 2021 | Oct 14, 2021 | Gordon Carl L Dir 10% | Buy | $16 | $10M | +3.58% |
| Oct 12, 2021 | Oct 14, 2021 | Shakespeare William | Buy | $16 | $10,000 | +0.16% |
| Oct 12, 2021 | Oct 14, 2021 | Rock Springs Capital Management LP 10% | Buy | $16 | $4M | +29.44% |
| Oct 12, 2021 | Oct 14, 2021 | Orbimed Advisors LLC Dir 10% | Buy | $16 | $10M | +3.58% |
| Oct 12, 2021 | Oct 14, 2021 | Omega Fund Vi, L.P. Former 10% owner | Buy | $16 | $3M | +20.86% |
| Aug 07, 2015 | Aug 07, 2015 | Glaxosmithkline Plc 10% | Buy | $14.18 | $3M | +0.76% |
| Jun 02, 2015 | Jun 04, 2015 | Tyree James L Dir | Sell | $16.85 | $41,080 | -6.84% |
| May 27, 2015 | May 29, 2015 | Waltrip William H Dir | Sell | $16.32 | $266,228 | -11.66% |
| May 11, 2015 | May 11, 2015 | Glaxosmithkline Plc 10% | Buy | $16 | $1M | +0.27% |
| Mar 02, 2015 | Mar 02, 2015 | Glaxosmithkline Plc 10% | Buy | $18.06 | $2M | +0.29% |
| Nov 04, 2014 | Nov 04, 2014 | Glaxosmithkline Plc 10% | Buy | $15.36 | $13M | +2.57% |
| Aug 13, 2014 | Aug 15, 2014 | Lee Junning SVP Technical Operations | Sell | $22.5 | $1M | -16.75% |
| Aug 11, 2014 | Aug 13, 2014 | Shafer Bradford J SVP Gen. Counsel Secretary | Sell | $22.13 | $622,999 | -5.83% |
| Aug 11, 2014 | Aug 11, 2014 | Glaxosmithkline Plc 10% | Buy | $22.66 | $4M | +0.56% |
| May 09, 2014 | May 13, 2014 | Glaxosmithkline Plc 10% | Buy | $26.89 | $9M | +1.03% |